Drug
Ribociclib
Ribociclib: highest development phase Phase 3, developed by Novartis. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ribociclib NCT05827081 | Phase 3 | Early Breast Cancer |
| ribociclib (LEE011) NCT01857193 | Phase 1 | Breast Cancer |
Latest
Follow Ribociclib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.